Erratum to: Liver Stem/Progenitor Cells in the Canals of Hering: Cellular Origin of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi? (Stem Cell Reviews and Reports, 10.1007/s12015-010-9188-4);Liver Stem/Progenitor Cells in the Canals of Hering: Cellular Origin of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi?

Stem Cell Reviews and Reports

Volumn 6, Issue 4, 2010, Pages 579-584

  Peng, Ningfu ^a   Li, Lequn ^b   Cai, Xiang ^c   Tan, Shaozao ^c   Wu, Ting ^c  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Bile duct tumor thrombi; Canals of Hering; Clinicopathologic features; Hepatocellular carcinoma; Liver cancer stem cell; Liver stem progenitor cell

Indexed keywords

EID: 77957353560     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9262-6     Document Type: Erratum

References (60)

1. Lin, T. Y., Chen, K. M., Chen, Y. R., Lin, W. S., Wang, T. H., & Sung, J. L. (1975). Icteric type hepatoma. Médecine & Chirurgie Digestives, 4, 267-270.
2. Okita, K. (2006). Clinical aspects of hepatocellular carcinoma in Japan. Internal Medicine, 45, 229-233.
3. Ueda, M., Takeuchi, T., Takayasu, T., Takahashi, K., Okamoto, S., Tanaka, A., et al. (1994). Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi. Hepatogastroenterology, 41, 349-354.
4. Shiomi, M., Kamiya, J., Nagino, M., Uesaka, K., Sano, T., Hayakawa, N., et al. (2001). Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery, 129, 692-698.
5. Liu, Q., Chen, J., Li, H., Liang, B., Zhang, L., & Hu, T. (2009). Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance imaging features to histopathologic manifestations. European Journal of Radiology, 4389, 1-7.
6. Qin, L. X., Ma, Z. C., Wu, Z. Q., Fan, J., Zhou, X. D., Sun, H. C., et al. (2004). Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. World Journal of Gastroenterology, 10, 1397-1401.
7. Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
8. Gaudio, E., Carpino, G., Cardinale, V., Franchitto, A., Onori, P., & Alvaro, D. (2009). New insights into liver stem cells. Digestive and Liver Disease, 41, 455-462.
9. Theise, N. D., Saxena, R., Portmann, B. C., Thung, S. N., Yee, H., Chiriboga, L., et al. (1999). The canals of Hering and hepatic stem cells in humans. Hepatology, 30, 1425-1433.
10. De Alwis, N., Hudson, G., Burt, A. D., Day, C. P., & Chinnery, P. F. (2009). Human liver stem cells originate from the canals of Hering. Hepatology, 50, 992-993.
11. Fellous, T. G., Islam, S., Tadrous, P. J., Elia, G., Kocher, H. M., Bhattacharya, S., et al. (2009). Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology, 49, 1655-1663.
12. Dolle, L., Best, J., Mei, J., Al Battah, F., Reynaert, H., van Grunsven, L. A., et al. (2010). The quest for liver progenitor cells: a practical point of view. Journal of Hepatology, 52, 117-129.
13. Spee, B., Carpino, G., Schotanus, B. A., Katoonizadeh, A., Vander, B. S., Gaudio, E., et al. (2010). Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut, 59, 247-257.
14. Yang, W., Yan, H. X., Chen, L., Liu, Q., He, Y. Q., Yu, L. X., et al. (2008). Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Research, 68, 4287-4295.
15. Hu, M., Kurobe, M., Jeong, Y. J., Fuerer, C., Ghole, S., Nusse, R., et al. (2007). Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology, 133, 1579-1591.
16. Apte, U., Thompson, M. D., Cui, S., Liu, B., Cieply, B., & Monga, S. P. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology, 47, 288-295.
17. Sicklick, J. K., Li, Y. X., Melhem, A., Schmelzer, E., Zdanowicz, M., Huang, J., et al. (2006). Hedgehog signaling maintains resident hepatic progenitors throughout life. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290, G859-G870.
18. Ma, S., Chan, K. W., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., et al. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 132, 2542-2556.
19. Dumble, M. L., Croager, E. J., Yeoh, G. C., & Quail, E. A. (2002). Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis, 23, 435-445.
20. Tanaka, S., Yamamoto, T., Tanaka, H., Kodai, S., Ogawa, M., Ichikawa, T., et al. (2005). Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence. Hepatology Research, 32, 52-57.
21. Zhang, F., Chen, X. P., Zhang, W., Dong, H. H., Xiang, S., Zhang, W. G., et al. (2008). Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology, 52, 224-232.
22. Bhagat, V., Javle, M., Yu, J., Agrawal, A., Gibbs, J. F., Kuvshinoff, B., et al. (2006). Combined hepatocholangiocarcinoma: case-series and review of literature. International Journal of Gastrointestinal Cancer, 37, 27-34.
23. Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., et al. (2004). Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Science, 95, 592-595.
24. Inaba, K., Suzuki, S., Sakaguchi, T., Kobayasi, Y., Takehara, Y., Miura, K., et al. (2007). Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis. J Hepatobiliary Pancreat Surg, 14, 204-209.
25. Chen, F., Li, S., & Castranova, V. (2009). Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. European Journal of Gastroenterology & Hepatology, 21, 1320-1321.
26. Lee, C. H., Chang, C. J., Lin, Y. J., Yeh, C. N., Chen, M. F., & Hsieh, S. Y. (2009). Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. British Journal of Cancer, 100, 1765-1770.
27. Zhou, H., Wang, H., Zhou, D., Wang, H., Wang, Q., Zou, S., et al. (2010). Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. European Journal of Cancer, 46, 1056-1061.
28. Li, L., & Neaves, W. B. (2006). Normal stem cells and cancer stem cells: the niche matters. Cancer Research, 66, 4553-4557.
29. Taniguchi, H., & Chiba, T. (2008). Stem cells and cancer in the liver. Disease Markers, 24, 223-229.
30. Chiba, T., Zheng, Y. W., Kita, K., Yokosuka, O., Saisho, H., Onodera, M., et al. (2007). Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology, 133, 937-950.
31. Yonemitsu, Y., Imazeki, F., Chiba, T., Fukai, K., Nagai, Y., Miyagi, S., et al. (2009). Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma. Human Pathology, 40, 1304-1311.
32. Wang, H., Pan, K., Zhang, H. K., Weng, D. S., Zhou, J., Li, J. J., et al. (2008). Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 134, 535-541.
33. Lee, J. S., Heo, J., Libbrecht, L., Chu, I. S., Kaposi-Novak, P., Calvisi, D. F., et al. (2006). A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Natural Medicines, 12, 410-416.
34. Lee, T. K., Castilho, A., Ma, S., & Ng, I. O. (2009). Liver cancer stem cells: implications for a new therapeutic target. Liver International, 29, 955-965.
35. Chiba, T., Kita, K., Zheng, Y. W., Yokosuka, O., Saisho, H., Iwama, A., et al. (2006). Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 44, 240-251.
36. Song, W., Li, H., Tao, K., Li, R., Song, Z., Zhao, Q., et al. (2008). Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. International Journal of Clinical Practice, 62, 1212-1218.
37. Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., et al. (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Research, 68, 1451-1461.
38. Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H. Y., et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 136, 1012-1024.
39. Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007). Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Research, 67, 10831-10839.
40. Schmelzer, E., Wauthier, E., & Reid, L. M. (2006). The phenotypes of pluripotent human hepatic progenitors. Stem Cells, 24, 1852-1858.
41. Mallory, T. B., Castleman, B., & Parris, E. E. (1947). Case records of the Massachusetts General Hospital; case 33441. The New England Journal of Medicine, 237, 673-676.
42. Kojiro, M., Kawabata, K., Kawano, Y., Shirai, F., Takemoto, N., & Nakashima, T. (1982). Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer, 49, 2144-2147.
43. Satoh, S., Ikai, I., Honda, G., Okabe, H., Takeyama, O., Yamamoto, Y., et al. (2000). Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery, 128, 779-783.
44. Narita, R., Oto, T., Mimura, Y., Ono, M., Abe, S., Tabaru, A., et al. (2002). Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma. Journal of Gastroenterology, 37, 55-58.
45. Yeh, C. N., Jan, Y. Y., Lee, W. C., & Chen, M. F. (2004). Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World Journal of Surgery, 28, 471-475.
46. Peng, B. G., Liang, L. J., Li, S. Q., Zhou, F., Hua, Y. P., & Luo, S. M. (2005). Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World Journal of Gastroenterology, 11, 3966-3969.
47. Xiangji, L., Weifeng, T., Bin, Y., Chen, L., Xiaoqing, J., Baihe, Z., et al. (2009). Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbeck's Archives of Surgery, 394, 1033-1039.
48. Zhou, X. D., Tang, Z. Y., Fan, J., Zhou, J., Wu, Z. Q., Qin, L. X., et al. (2009). Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5, 829 patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 135, 1073-1080.
49. Andersen, J. B., Loi, R., Perra, A., Factor, V. M., Ledda-Columbano, G. M., Columbano, A., et al. (2010). Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology, 51, 1401-1409.
50. Ohyama, M., Terunuma, A., Tock, C. L., Radonovich, M. F., Pise-Masison, C. A., Hopping, S. B., et al. (2006). Characterization and isolation of stem cell-enriched human hair follicle bulge cells. Journal of Clinical Investigation, 116, 249-260.
51. Sell, S. (2001). Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology, 33, 738-750.
52. Sell, S. (1993). Cellular origin of cancer: dedifferentiation or stem cell maturation arrest. Environmental Health Perspectives, 101(Suppl 5), 15-26.
53. Roskams, T., De Vos, R., & Desmet, V. (1996). 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology, 28, 291-299.
54. Libbrecht, L., Desmet, V., van Damme, B., & Roskams, T. (2000). The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. Journal of Hepatology, 33, 76-84.
55. Le, B. B., Faouzi, S., Boussarie, L., Balabaud, C., Bioulac-Sage, P., & Rosenbaum, J. (1997). Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver. The Journal of Pathology, 181, 330-337.
56. Libbrecht, L., De Vos, R., Cassiman, D., Desmet, V., Aerts, R., & Roskams, T. (2001). Hepatic progenitor cells in hepatocellular adenomas. The American Journal of Surgical Pathology, 25, 1388-1396.
57. Hsia, C. C., Evarts, R. P., Nakatsukasa, H., Marsden, E. R., & Thorgeirsson, S. S. (1992). Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology, 16, 1327-1333.
58. Sell, S., & Leffert, H. L. (2008). Liver cancer stem cells. Journal of Clinical Oncology, 26, 2800-2805.
59. Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J., & Avila, M. A. (2009). Inflammation and liver cancer: new molecular links. Annals of the New York Academy of Sciences, 1155, 206-221.
60. Marrero, C. R., & Marrero, J. A. (2007). Viral hepatitis and hepatocellular carcinoma. Archives of Medical Research, 38, 612-620.